Glutaraldehyde-treated Autologous Pericardium Used in Valve Repairs
Download in electronic PDF format for $75
Abstract: In the 1960s and 1970s, mitral valve replacement was the highest risk of all cardiac procedures, with a 20% to 30% mortality rate. Fortunately, there have been major advancements in the procedures for repair or replacement of heart valves. Some of the newer surgical procedures have become far less invasive and hospital stays have been shortened. One of these advancements is the use of autologous pericardium, commonly known as a pericardial patch. Since the procedure uses the patient’s own pericardial tissue, the immune reaction factor is eliminated. The use of a glutaraldehyde soaking technique to strengthen the pericardial tissue in the replacement and repair procedure for mitral valve replacement is discussed in this article. The preparation of the glutaraldehyde soaking solution is a high-risk procedure, and compounding pharmacists play a very important role in properly preparing the glutaraldehyde soaking solution for the cardiovascular surgeon.
Related Keywords:
Linda F. McElhiney, PharmD, RPh, FIACP, FASHP, glutaraldehyde soaking solution, autologous pericardium, mitral valve replacement, heart valve disorders, valvular disease, dialdehyde sterilant, formulation
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Glutaraldehyde-treated Autologous Pericardium Used in Valve Repairs
McElhiney Linda F
|
Jan/Feb 2012
Pg. 12-16
|
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R, Fox Samantha, Mixon William, Vail Jane
|
Jan/Feb 2012
Pg. 34-41
|
Treating Canine Hepatic Disease
Davidson Gigi S
|
May/Jun 2003
Pg. 188-191
|
Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
|
Jul/Aug 2003
Pg. 288-291
|
The Treatment of Canine Atopic Disease
Davidson Gigi S
|
May/Jun 2002
Pg. 210-215
|
Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 46-48
|
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Mixon William, Angelle Patricea (Patsy), Chang Richard I
|
Nov/Dec 2009
Pg. 506-515
|
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops
Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
|
Nov/Dec 2009
Pg. 540-543
|
Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
|
Jul/Aug 2011
Pg. 302-307
|
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease
McElhiney Linda F
|
May/Jun 2012
Pg. 190-195
|
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Bramwell Bethany L
|
Mar/Apr 2010
Pg. 108-111
|
Case Report: Pediatric Scar Management After Open-heart Surgery
Phan Ha, Harger Beau, Estrada Nick
|
Jul/Aug 2016
Pg. 277-280
|
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
|
Sep/Oct 2014
Pg. 370-377
|
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
|
Jul/Aug 2011
Pg. 290-300
|
PreScription: The International Academy of Compounding Pharmacists Remembers Evelyn Timmons, RPh, FIACP, and George Roentsch, RPh, FIACP
Karolchyk Scott
|
Jan/Feb 2012
Pg. 4
View Sample |
Prevention Is the Best Medicine: Don J. Bottoni, RPh, FACA, FIACP
Bottoni Don J
|
Jan/Feb 2004
Pg. 22-27
|
The Science Behind Hormone Replacement Therapy, Part 1
Wepfer Scott T
|
Nov/Dec 2001
Pg. 462-464
|
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists
Macklin Denise, Blackburn Paul L
|
Mar/Apr 2013
Pg. 100-110
|
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
|
Sep/Oct 2013
Pg. 380-383
|
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 481-486
|
| Return to Top |
